{
    "organizations": [],
    "uuid": "12a59a70ad84fbe00714e31ff3cc467826df270c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cadila-healthcare-says-zydus-gets/brief-cadila-healthcare-says-zydus-gets-final-approval-from-u-s-fda-for-diclofenac-sodium-topical-solution-idUSFWN1RV0Z2",
    "ord_in_thread": 0,
    "title": "BRIEF-Cadila Healthcare Says Zydus Gets Final Approval From U.S. FDA For Diclofenac Sodium Topical Solution",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 19 (Reuters) - Cadila Healthcare Ltd:\n* SAYS ZYDUS GETS FINAL APPROVAL FROM U.S. FDA FOR DICLOFENAC SODIUM TOPICAL SOLUTION\n* SAYS IT SOLUTION TO BE MANUFACTURED AT GROUP'S TOPICAL MANUFACTURING FACILITY AT AHMEDABAD Source text - bit.ly/2HLzxSa Further company coverage:\n ",
    "published": "2018-04-19T12:11:00.000+03:00",
    "crawled": "2018-04-20T11:50:10.034+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "cadila",
        "healthcare",
        "ltd",
        "say",
        "zydus",
        "get",
        "final",
        "approval",
        "fda",
        "diclofenac",
        "sodium",
        "topical",
        "solution",
        "say",
        "solution",
        "manufactured",
        "group",
        "topical",
        "manufacturing",
        "facility",
        "ahmedabad",
        "source",
        "text",
        "company",
        "coverage"
    ]
}